| Alice Lee Grest, MS, CCC-SLP | |
|
1371 Hecla Dr Ste D130, Louisville, CO 80027-2327 | |
| (303) 963-5582 | |
| Not Available |
| Full Name | Alice Lee Grest |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1371 Hecla Dr Ste D130, Louisville, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326805474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP.0005699 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alice Lee Grest, MS, CCC-SLP 1461 Monroe Pl, Louisville, CO 80027-1560 Ph: (530) 329-5778 | Alice Lee Grest, MS, CCC-SLP 1371 Hecla Dr Ste D130, Louisville, CO 80027-2327 Ph: (303) 963-5582 |
News Archive
RL Solutions, creators of innovative and easy-to-use healthcare quality and safety software, announced today the general availability of its new incident and patient feedback reporting app, RL6:Mobile.
Synthorx Inc. announced today that the company has employed its proprietary protein expression system to successfully produce proteins containing novel amino acids. Using a semi-synthetic DNA template (containing the synthetic base pair X and Y), Synthorx scientists were able to produce RNA containing X and Y, which was used with an otherwise fully natural biological system, to efficiently direct the incorporation of multiple novel amino acids at different sites in proteins.
Researchers at Columbia University Medical Center have identified a defect in the T cell regulatory pathway which normally controls autoreactive T cells that attack the body's own tissues and organs. A majority of people with Type 1 diabetes who were tested in the study were found to have the newly-identified cellular/molecular defect, and the researchers were able to successfully correct the defect in-vitro.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.
People are more likely to wash their hands when they have been shamed into it, according to a study by the London School of Hygiene & Tropical Medicine
› Verified 5 days ago
Maureen Elizabeth Creswell, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1855 Plaza Dr, Louisville, CO 80027 Phone: 303-926-3849 Fax: 303-604-6573 | |
Chesni Rae Carter, M.S. SLP-CF Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1855 Plaza Dr, Louisville, CO 80027 Phone: 303-926-3849 | |
Speech Language Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 810 Flatirons Ct, Louisville, CO 80027 Phone: 720-254-6444 Fax: 413-691-9444 | |
Ms. Simone Carol Olsberg, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1027 Turnberry Cir, Louisville, CO 80027 Phone: 303-870-9302 Fax: 303-433-1574 | |
Nancy Sims Ma Ccc-slp Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 357 Mccaslin Blvd Ste 200, Louisville, CO 80027 Phone: 720-308-5426 | |
Nancy Sims, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 357 Mccaslin Blvd Ste 200, Louisville, CO 80027 Phone: 720-308-5426 |